2d:I[856015,["/_next/static/immutable/chunks/1xzisbplk9czp.js","/_next/static/immutable/chunks/3j2i1faptc_-9.js","/_next/static/immutable/chunks/0fma7nlq6immz.js","/_next/static/immutable/chunks/08tq8rmv423j5.js","/_next/static/immutable/chunks/1chr5wkk3j58k.js","/_next/static/immutable/chunks/37kmmh_zm4dov.js","/_next/static/immutable/chunks/311zvdjfxff-f.js","/_next/static/immutable/chunks/1a_hqhrsle_n_.js"],"default"] 2e:T522a,

Summary Table

Category	Details
Risk Factors	White women, age 20-40, family history (autosomal dominant with incomplete penetrance), pregnancy (accelerates progression)
Etiology	Abnormal bone remodeling at the otic capsule, most commonly at the fissula ante fenestram (anterior to the oval window), leading to stapes footplate fixation
Patient Presentation	Progressive, bilateral conductive hearing loss in a young adult; patient may report hearing better in noisy environments (paracusis of Willis)
Classic Physical Exam	Normal-appearing tympanic membrane, Schwartze sign (reddish/pinkish hue on promontory seen through intact TM due to hypervascular otospongiotic bone), negative Rinne test (bone conduction > air conduction), Weber test lateralizes to the affected ear
Key Diagnostic Results	Audiometry: conductive hearing loss with Carhart notch (characteristic dip at 2000 Hz on bone conduction); tympanometry: Type As (reduced compliance/stiff); absent acoustic reflexes
Management	Hearing amplification (hearing aids) for mild cases; stapedectomy/stapedotomy is the definitive surgical treatment; sodium fluoride for medical management to slow progression
Keywords	"Young woman with progressive hearing loss," "normal TM," "conductive hearing loss," "hears better in noise," "Carhart notch," "stapes fixation"

1. Pathophysiology

Otosclerosis is a disorder of abnormal bone remodeling that occurs exclusively within the otic capsule, which is the dense bone surrounding the inner ear. Under normal conditions, the otic capsule is one of the few bones in the body that does not undergo significant remodeling after formation. In otosclerosis, this quiescent bone is replaced by foci of disorganized, spongy, and eventually sclerotic bone.

The process begins at the fissula ante fenestram, a small cleft of fibrous tissue just anterior to the oval window. This is the most common site of involvement. The disease progresses through two phases. The early otospongiotic phase is characterized by highly vascular, immature bone that replaces the normal enchondral bone of the otic capsule. This is the phase responsible for the Schwartze sign, where increased vascularity of the promontory is visible through the intact tympanic membrane. Over time, this transitions into the otosclerotic phase, where the bone matures into dense, sclerotic tissue.

When the sclerotic bone encroaches on the stapes footplate, it progressively fixes the stapes to the oval window. Since the stapes is the final link in the ossicular chain responsible for transmitting sound vibrations from the tympanic membrane to the inner ear fluid, its fixation results in conductive hearing loss. Sound waves can no longer be efficiently transmitted mechanically, but bone conduction remains intact (or even artificially appears improved at certain frequencies, which explains the Carhart notch artifact).

In roughly 10% of cases, the otosclerotic focus extends to involve the cochlea itself (cochlear otosclerosis). When this happens, the disease damages the membranous labyrinth and cochlear structures, producing a sensorineural component on top of the conductive loss, resulting in mixed hearing loss. This variant carries a worse prognosis because the sensorineural component is irreversible.

The reason patients experience paracusis of Willis (improved hearing in noisy environments) is rooted in a simple auditory principle: in a loud setting, people with normal hearing raise their voices. The patient with conductive hearing loss does not perceive the background noise as loudly, but does perceive the raised voices more clearly, creating a paradoxical sense that they hear better in noise.

Pregnancy is a well-known accelerating factor. The hormonal changes, particularly estrogen, are thought to stimulate the remodeling activity at otosclerotic foci, which is why the disease disproportionately worsens during pregnancy and why women are affected approximately twice as often as men.

2. Classification and Clinical Manifestation

Type	Site of Involvement	Hearing Loss Pattern	Clinical Features
Stapedial (Fenestral) Otosclerosis	Stapes footplate / oval window region	Conductive hearing loss	Most common form; progressive hearing loss, normal TM, absent acoustic reflexes, amenable to surgery
Cochlear Otosclerosis	Otic capsule extending to cochlea	Mixed hearing loss (conductive + sensorineural)	Sensorineural component indicates cochlear involvement; worse prognosis; surgery corrects only the conductive component
Histologic Otosclerosis	Otic capsule (microscopic foci)	None (subclinical)	Found incidentally on temporal bone histopathology; clinically silent; far more prevalent than clinical otosclerosis

Stages

Stage	Pathologic Phase	Key Feature
Active (Otospongiotic)	Resorption of normal bone, replacement with vascular immature bone	Schwartze sign visible; more responsive to sodium fluoride therapy
Inactive (Otosclerotic)	Maturation into dense sclerotic bone	Stapes fixation established; less responsive to medical therapy

3. Diagnostic Workup

Test	Role	Expected Finding
Pure-tone audiometry	Best initial test	Conductive hearing loss; Carhart notch (artifactual dip in bone conduction at 2000 Hz)
Tympanometry	Supportive	Type As curve (normal pressure peak but reduced compliance, indicating a stiff system)
Acoustic reflex testing	Supportive	Absent or diminished stapedial reflexes (stapes is fixed and cannot contract)
Tuning fork tests	Bedside screening	Rinne negative (bone > air on affected side); Weber lateralizes to affected ear
High-resolution CT of temporal bones	Confirmatory imaging (when needed)	Lucency around the oval window (fenestral lucency) in active disease; sclerotic foci in later stages
Surgical exploration	Gold standard (historical)	Direct visualization of fixed stapes footplate; rarely done purely for diagnosis

The workup begins with pure-tone audiometry, which is the best initial test. It reveals conductive hearing loss, typically bilateral but often asymmetric. The hallmark finding is the Carhart notch, an artifactual depression in bone conduction thresholds at 2000 Hz. This is not a true sensorineural loss but rather a mechanical artifact caused by the mass-loading effect of the fixed stapes on bone conduction measurements. After successful stapedectomy, the Carhart notch resolves, confirming its artifactual nature.

Tympanometry shows a Type As curve. The "s" stands for "stiff" or "shallow," indicating reduced compliance of the tympanic membrane-ossicular system. This is a key differentiator: in otosclerosis, the TM itself is normal, but the overall system is stiff because the stapes cannot move. Contrast this with Type Ad (deep/flaccid) seen in ossicular chain discontinuity.

Acoustic reflex testing is particularly useful. In otosclerosis, reflexes are absent because the stapes is mechanically fixed and cannot contract even when the stapedius muscle fires. In early disease, you may see the on-off effect (a biphasic deflection pattern), which is considered pathognomonic for early otosclerosis before complete fixation.

High-resolution CT of the temporal bones is used when the diagnosis is uncertain or when surgical planning requires anatomical detail. In active otospongiotic disease, CT shows areas of lucency (radiolucency) around the fissula ante fenestram and the oval window. In the sclerotic phase, these areas become dense. CT is also important to rule out other causes of conductive hearing loss, such as superior semicircular canal dehiscence.

The gold standard for definitive diagnosis is surgical exploration with direct visualization and palpation of the stapes footplate, but this is almost never performed solely for diagnostic purposes. It is confirmed at the time of therapeutic stapedectomy.

4. Management and Treatment

Approach	Indication	Details
Observation	Minimal hearing loss, patient preference	Serial audiometry to monitor progression
Hearing aids	Mild-moderate conductive loss; patient declines surgery; surgical contraindication	Non-invasive; effective for conductive component
Stapedectomy / Stapedotomy	Definitive surgical treatment	Removal or fenestration of fixed stapes footplate, replacement with prosthesis; success rate >90%
Sodium fluoride	Active otospongiotic phase; adjunct to slow progression	Sodium fluoride 20-40 mg/day with calcium and vitamin D supplementation
Hearing aids + sodium fluoride	Cochlear otosclerosis with sensorineural component	Surgery corrects only conductive portion; sensorineural loss is irreversible

For patients with mild hearing loss or those who prefer to defer intervention, amplification with hearing aids is appropriate. This is a safe and effective option, particularly for elderly patients or those with surgical contraindications.

The definitive treatment is stapedectomy (complete removal of the stapes and replacement with a prosthesis) or stapedotomy (creation of a small fenestration in the stapes footplate with insertion of a piston prosthesis). Stapedotomy is now the preferred technique because it is associated with lower rates of sensorineural hearing loss and perilymph fistula compared to total stapedectomy. The prosthesis is typically crimped onto the long process of the incus and inserted into the oval window fenestration, restoring mechanical transmission of sound.

Surgical success rates exceed 90% for closure of the air-bone gap. However, surgery should only be performed on the worse-hearing ear first, so that if a rare complication (such as sensorineural hearing loss) occurs, the patient still has a functioning better ear.

Contraindications to surgery include an only-hearing ear (relative contraindication), active middle ear infection, and poor general health. In patients with cochlear otosclerosis and a prominent sensorineural component, surgery will only correct the conductive portion; the sensorineural loss is permanent.

Sodium fluoride (20-40 mg/day, typically given as sodium fluoride 25 mg twice daily) is used as medical therapy to slow disease progression, particularly in the active otospongiotic phase. Fluoride is incorporated into bone, converting hydroxyapatite to fluorapatite, which is more resistant to resorption and slows the osteoclastic activity driving the disease. It is given with calcium carbonate and vitamin D to prevent fluoride-related osteomalacia. Medical therapy does not reverse existing hearing loss but may stabilize it.

For patients with bilateral disease, the ear with worse hearing is treated surgically first. The contralateral ear can be addressed in a subsequent procedure, typically after a waiting period of at least 6-12 months.

5. Differential Diagnosis and Distractors

Differential Diagnosis	Why It Is Similar	Key Discriminator
Ossicular chain discontinuity	Conductive hearing loss with normal TM	Tympanometry shows Type Ad (hypercompliant/flaccid), not Type As; usually follows trauma or chronic infection
Tympanosclerosis	White plaques on TM; conductive hearing loss	TM is visibly abnormal (chalky white patches); history of recurrent otitis media
Superior semicircular canal dehiscence (SSCD)	Conductive hearing loss with normal TM; Carhart-like notch possible	Air-bone gap predominantly at low frequencies; associated with autophony, Tullio phenomenon (vertigo with loud sounds); CT shows bony dehiscence of superior canal
Chronic otitis media with effusion	Conductive hearing loss	TM is abnormal (retracted, dull, amber fluid level); tympanometry shows Type B (flat)
Presbycusis	Progressive hearing loss in adults	Sensorineural pattern (high-frequency loss); occurs in elderly; Rinne is positive (normal); no air-bone gap
Cholesteatoma	Conductive hearing loss; may have normal-appearing TM initially	Usually presents with foul-smelling otorrhea, retraction pocket, or white keratin debris; may erode ossicles
Paget disease of bone	Can affect the temporal bone and cause hearing loss	Systemic disease with elevated alkaline phosphatase, bone pain, skull enlargement; hearing loss is typically mixed and occurs in older patients

6. Traps and High-Yield Pearls

The single most common way students miss otosclerosis questions is by not recognizing the normal tympanic membrane. When a vignette presents progressive conductive hearing loss, many students reflexively think of middle ear pathology such as chronic otitis media or cholesteatoma, both of which produce visible TM abnormalities. The test-writer is counting on you to notice the phrase "normal otoscopic examination" or "normal-appearing tympanic membrane" and immediately consider otosclerosis.

The second major trap involves tympanometry interpretation. Students frequently confuse Type As (stiff, reduced compliance) with Type Ad (flaccid, increased compliance). Otosclerosis produces a stiff system because the stapes is fixed. Ossicular discontinuity produces a flaccid system because the chain is broken and the TM moves freely. Getting these two reversed is a common error.

Another classic trap is the Carhart notch. Students may see the dip at 2000 Hz on bone conduction and incorrectly interpret this as sensorineural involvement, leading them to classify the hearing loss as mixed. Remember, the Carhart notch is an artifact of stapes fixation that disappears after successful surgery.

Finally, be alert for the pregnancy connection. A vignette describing a young woman whose hearing loss worsened during or after pregnancy is a strong clue for otosclerosis. The core competency being tested is pattern recognition: the combination of a young woman, progressive conductive hearing loss, normal TM, and absent acoustic reflexes should trigger immediate recognition of otosclerosis as the diagnosis, with stapedotomy as the definitive treatment.

1e:["$","$L2d",null,{"article":{"id":"2883a7f6-354a-4bf6-bd3e-379dc9faf1ec","title":"Otosklerosis","content":"$2e","category":"THT-KL","created_at":"2026-05-14T04:58:32.668006+00:00","status":"published","subcategory":null},"questionCount":6,"sections":[{"id":"section-pathophysiology","num":"01","title":"Pathophysiology"},{"id":"section-classification-and-clinical-manifestation","num":"02","title":"Classification and Clinical Manifestation"},{"id":"section-diagnostic-workup","num":"03","title":"Diagnostic Workup"},{"id":"section-management-and-treatment","num":"04","title":"Management and Treatment"},{"id":"section-differential-diagnosis-and-distractors","num":"05","title":"Differential Diagnosis and Distractors"},{"id":"section-traps-and-high-yield-pearls","num":"06","title":"Traps and High-Yield Pearls"}],"hasSummaryTable":true}]